Cardioprotective effects of Curcuma longa L. extracts against doxorubicin-induced cardiotoxicity in rats

Journal of Medicinal Plants Research

Volumn 5, Issue 17, 2011, Pages 4049-4058

  El Sayed, Eman M ^a   Abd El azeem, Amal S ^a   Afify, Abeer A ^a   Shabana, Manal H ^a   Ahmed, Hanaa H ^a  

^a NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

Antioxidants; Cardiotoxicity; Curcume longa l.; Doxorubicin

Indexed keywords

ALCOHOL; ASCORBIC ACID; CALCIUM; CATALASE; CREATINE KINASE MB; CURCUMA LONGA EXTRACT; DOXORUBICIN; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUTATHIONE; HEMOGLOBIN; IRON; LACTATE DEHYDROGENASE; LIPID PEROXIDE; MALONALDEHYDE; NITRIC OXIDE; POLYPHENOL DERIVATIVE; THIOCTIC ACID; TURMERIC; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; BODY WEIGHT; CARDIOMYOPATHY; CARDIOTOXICITY; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; HEART PROTECTION; HEART WEIGHT; IN VIVO STUDY; IRON BLOOD LEVEL; LIPID PEROXIDATION; MALE; MORTALITY; NONHUMAN; OXIDATIVE STRESS; PROTEIN CONTENT; RAT; RHIZOME;

CURCUMA LONGA; RATTUS;

EID: 80052844193     PISSN: None     EISSN: 19960875     Source Type: Journal    
DOI: None     Document Type: Article

References (88)

1. Abd El-Gawad HM, EL-Sawalhi MM (2004). Nitric oxide and oxidative stress in brain and heart of normal rats treated with doxorubicin: role of aminoguanidine. J. Biochem. Mol. Toxicol., 18(2): 69-77.
2. Abd-Allah AR, Al - Majed AA, Mostafa AM, Al-Shabanah OA, Din AG, Nagi MN (2002). Protective effect of arabic gum against cardiotoxicity induced by doxorubicin in mice: a possible mechanism for protection. J. Biochem. Mol. Toxicol., 16(5): 254-259.
3. Aebi H (1984). Catalase in vitro. Methods Enzymol., 105: 121-126.
4. Aggarwal BB, Kumar A, Bharti AC (2003). Anticancer potential of curcumin: Preclinical and clinical studies. Anticancer Res., 23: 363- 398.
5. Ahmed HH, Monna F, Elmegeed GA, Doss SH (2005). Cardioprotective activity of melatonin and its novel synthesized derivative on doxorubicin - induced cardio toxicity. Bioorg. Med. Chem., 13: 1847- 1857.
6. Angelini A, Lezzi M, Difebbo CD, Ilio C, Cuccurullo F, Porreca E (2008). Reversal of P. glycoprotein mediated multidrug resistance in human sarcoma MES-SA/DX-5 Cells by non steroidal anti-inflammatory drugs. Oncol. Rep., 20(4): 731-735.
7. 2+ ATPase gene transcription. Circ. Res., 86: 8-14.
8. Arora A, Nair MG, Strasburg M (1998). Antioxidant activities of isoflavones and their biological metabolites in a liposomal system. Arch. Biochem. Biophys., 356(2): 133-141.
9. Bagchi D, Sen CK, Ray SD, Das DK, Bagchin M, Prenss HG, Vinson JA (2003). Molecular mechanisms of cardioprotection by a novel grape seed proanthocyanidin extract. Mutat. Res., 523-524: 87-97.
10. Balachandar AV, Malarkodi KP, Varalakshmi P (2003). Protective role of DL. alpha lipoic acid against adriamycin. induced cardiac lipid peroxidation. Hum. Exp. Toxicol., 22(5): 249-254.
11. Bertinchant JP, Polge A, Juan JM, Oliva - Lauraire MC, Giuliani I (2003). Evaluation of cardiac troponin I and T levels as markers of myocardial damage in doxorubicin - induced cardiomyopathy rats, and their relationship with echo cardiographic and histological findings. Clin. Chim. Acta, 329(1-2): 39-51.
12. 2+ ATP ase in cardiomyocytes of adriamycin treated rats. J. Zhejiang Univ. Sci., 6(7): 622-625.
13. 2+ ATP ase in cardiomyocytes of adriamycin treated rats. J. Zhejiang Univ. Sci., 6(7): 622-625.
14. Childs AC, Phaneuf SL, Dirks AJ, Phillips T, Leeuwen burgh C (2002). Doxorubicin treatment in vivo causes cytochrome C release and cardiomyocyte apoptosis as well as increased mitochondrial efficiency, superoxide dismutase activity, and BCl2: Bax ratio. Cancer Res., 62(16): 4592-4614.
15. De Beer EL, Bottone AE, Voes EE (2001). Doxorubicin and mechanical performance of cardiac trabeculae after acute and chronic treatment. Eur. J. Pharmacol., 415: 1-11.
16. Deepa PR, Varalakshmi P (2003). Protective effect of low molecular weight heparin on oxidative injury and cellular abnormalities in adriamycin induced cardiac and hepatic toxicity. Chemico - Biological interactions, 146: 201-210.
17. Dowd NP, Scully M, Adderley SR, Cunningham AJ, Fitzgerald DJ (2001). Inhibition of cyclo-oxygenase-2 aggrevates doxorrubicin mediated cardiac injury in vivo J. Clin. Invest., 108(4): 585-590.
18. Dowd NP, Scully M, Adderley SR, Cunningham AJ, Fitzgerald DJ (2001). Inhibition of cyclooxygenase - 2 - aggravates doxorubicin - mediated cardiac injury in vivo. J. Clin. Invest., 108: 585-590.
19. Dziegiel P, Murawska E, Jethon Z, Januszewska L, Podhorska - Okolow M, Surowiak P, Zawadzki M, Rabczynski J, Zabel M (2003). Melatonin stimulates the activity of protective antioxidative enzymes in myocardial cells of rats in the course of doxorubicin intoxication. J. Pineal Res., 35: 183-187.
20. EL-Missiry MA, Othman AI, Amer MA, Abd El-Aziz MA (2001). Attenuation of the acute adriamycin induced cardiac and hepatic oxidative toxicity by N-(2-ercaptopropionyl) glycine in rats. Free Radical Res., 35(5): 575-581.
21. Ferreria AA, Yeum KJ, Matsubara LS, Matsubara BB, Correa CR, Pereira EJ, Russell RM, Krinsky NI, Tang G (2007). Doxorubicin as antioxidant: Maintenance of myocardial levels of lycopene under doxorubicin treatment. Free Rad. Biol. Med., 43: 740-751.
22. Fryer RA, Galustian C, Dalgelish AG (2009). Recent advances and developments in treatment strategies against pancreatic cancer. Curr. Clin. Pharmacol., 4(2): 102-112.
23. Garner AP, Paine MJ, Chinje EC, Ortize P, Strat Ford IJ, Tew DG, Wolf CR (1999). Nitric oxide synthases catalyse the activation of redox cycling and bioreductive anticancer agents. Cancer Res 59: 1929-1934.
24. Gindler M, King JD (1972). Chemical method for determination of calcium in serum. Am. J. Clin. Pathol., 58: 376.
25. Goormaghtigh E, Rysschaert JM (1984). Anthracycline - glycoside membrane interactions. Biochim. Biophys. Acta, 779: 271-288.
26. Hamza A, Amin A, Daoud S (2008). The protective effect of a purified extract of Withania somnifera against doxorubicin - induced cardiac toxicity in rats. Cell Biol. Toxicol., 24(1): 63-73.
27. Heffner JE, Repine JE (1989). Pulmonary strategies of antioxidant defense. Am. Rev. Respir. Dis., 140: 531.
28. Herman EH, Ferrans V, Young RSK, Hamlin RL (1988). Effects of pretreatment with ICRF-187 on the total cumulative dose of doxorubicin tolerated by beagle dogs. Cancer Res., 48: 6918-6925.
29. Herman EH, Zhang J, Chadwick DP, Ferrans V (2000). Comparison of the protective effects of amifostine and dexrazoxane against toxicity of doxorubicin in spontaneously hypertensive rats. Cancer Chemother. Pharmacol., 45: 329-334.
30. 2+ transport myocardiac protection in rabbits. J Zhejiang Univ. Sci., 4: 114-120.
31. Ito H, Miller SC, Billingham ME, Akimoto H, Torti SV, Wade R, Gahlmann R, Lyons G, Kedes L, Torti FM (1990). Doxorubicin selectively inhibits muscle gene expression in cardiac muscle in vivo and in vitro. Proc. Natl. Acad. Sci., 87: 4275-4279.
32. Jagota SK, Dani HM (1982). Anew colorimetric technique for the estimation of vitamin C using folin phenol reagent. Anal. Biochem., 127: 178-182.
33. Jensen BV, Skovsgaard T, Nielsen SI (2002). Functional monitoring of anthracycline cardiotoxicity: a prospective - blinded long term observational study of outcome in 120 patients. Ann. Oncol., 13: 699- 709.
34. Kagan VE, Shavedova A, Serbinova E, Khan S, Swanson C, Powell R. (1992). Dihydrolipoic acid a universal antioxidant both in membrane and in the aqueous phase. Reduction of peroxyl, ascorbyl and chromanoxyl radicals. Biochem. Pharmacol., 44: 1637-1649.
35. Kelishomi RB, Ejtemaeemehr S, Tavangar SM, Rahimian R, Mobarakeh JI, Dehpour AR (2008). Morphine is protective against doxorubicin induced cardiotoxicity in rats. Toxicology, 243: 96-104.
36. 2+ increase are reciprocally modulated in rat cardiomyocytes. Exp. Mol. Med., 38(5): 535-45.
37. Kim YS, Park HJ, Joo SY, Hong MH, Kim KH, Hong YJ, Kim JH, Park HW, Jeong MH, Cho JG, Park JC, Ahn Y (2008). The protective effect of curcumin on myocardial ischemia reperfusion injury. Korean Circ. J., 38: 353-359.
38. Konorev EA, Kotamraju S, Zhao H, Kalivendi S, Joseph J, kalyanaraman B (2002). Paradoxical effects of metalloporphyrins on doxorubicin - induced apoptosis: Scavenging of reactive oxygen species versus induction of heme oxygenase-1. Free Radical Biol. Med., 33: 988.
39. Koracevic D, Koracevic G, Djordjevic V, Andrejevic, S, Cosic V (2001). Method for the measurement of antioxidant activity in human fluid. J. Clin. Pathol., 54: 356-361.
40. Kotamraju S, Chitambar CR, Kalivendi SV, Joseph J, Kalyanaraman B (2002). Transferrin receptor dependent iron uptake is responsible for doxorubicin mediated apoptosis in endothelial cells: role of oxidant induced iron signaling in apoptosis. J. Biol. Chem., 272: 17179- 17187.
41. Kumar SA, Sudhahar V, Varalakshmi P (2005). Attenuation of serum lipid abnormalities and cardiac oxidative stress by eicosapentaenoate. lipoate derivative in experimental hypercholesterolemia. Clin. Chim. Acta, 355: 197-204.
42. Kumar SA, Sudhahar V, Varalakshmi P (2005). Attenuation of serum lipid abnormalities and cardiac oxidative stress by eicosapentaenoatelipoate derivative in experimental hypercholesterolemia. Clin. Chim. Acta, 355: 197-204.
43. Langdon RG (1966). Glucose-6-phosphate dehydrogenase from erythrocytes. Methods Enzymol., 9: 126-131.
44. Lee HS (2006). Antiplutelet property of Curcuma longa L. rhizome derived ar. turmerone. Bioresour. Technol., 97: 1372-1376.
45. Li T, Dane L, Land S, PK (2002). Early changes in myocardial antioxidant enzymes in rats treated with adriamycin. Mol. Cell Biochem., 232: 19-26.
46. Lowry OH, Rosebrough NL, Farr AL, Randall RJ (1951). Protein measurement with the folin phenol reagent. J. Biol. Chem., 193: 265- 275.
47. 2+ handing in isolated cardiac myocytes. Jpn. Circ., 62: 505-511.
48. Martin E, Thougaard AV, Grauslund M, Jensen PB, Bjorkling F, Hasinoff BB, Sehested M, Jensen LH (2009). Evaluation of topoisomerase II- inactive bisdioxo piperazine ICRF-161 as a protectant against doxorubicin- induced cardiomyopathy. Toxicol., 255(1-2): 72-79.
49. Minotti G, Ronchi R, Salvatorelli E, Menna P, Gaetano Cairo G (2001). Dox Nirreversibly inactivates iron regulatory proteins 1 and 2 in cardiomyocytes: Evidence for distinct metabolic pathways and implications for iron - mediated cardio toxicity of antitumor therapy. Cancer Res., 61: 8422-8428.
50. Mohamed RH, El-Bastawesy AM, Zekry ZK, Al-Mehdar HA, Al-said MGA, Aly SS, Sharawy SM, El-Merzabani MM (2009). The role of Curcuma longa against doxorubicin (adriamycin)-induced toxicity in rats. J. Med. Food, 12(2): 394-402.
51. Montgomery HAC, Dymock JF (1961). The determination of nitrite in water. Analyst, 86: 414-416.
52. Moron MS, Depierre JW, Mannervik B (1979). Levels of glutathione, glutathione reductase and glutathione -S- transferase activities in rat lung and liver - Biochim- Biophys. Acta, 582: 67-78.
53. Mythili Y, Sudharsan PT, Amudha G, Varalakshmi P (2007). Effect of DL. alpha - lipoic acid on cyclophosphamide induced lysosomal changes in oxidative cardiotoxicity. Life Sci., 80(2): 1993-1998.
54. Notarbartolo M, Poma P, Perri D, Dusonchet L, Cervello M, D'Alessandro N (2005). Antitumor effects of curcumin alone or in combination with cisplatin or doxorubicin on human hepatic cancer cells. Analysis of their possible relationship to changes in NF-KB activation levels and in IAP gene expression. Cancer let., 224(1): 53- 65.
55. Nowak D, Pierscinski G, Drzewoski J (1995). Ambroxol inhibits doxorubicin induced lipid peroxidation in mice. Free Rad. Biol. Med., 19: 659-663.
56. Olson RD, Mushlin PS (1990). Doxorubicin cardiotoxicity analysis of prevailing hypotheses. FASEB J., 4: 3076-3086.
57. Othman AI, El-Missiry MA, Amer MA, Arafa M (2008). Melatonin controls oxidative stress and modulates iron, ferritin, and transferrin levels in adriamycin treated rats. Life Sci., 83: 653-658.
58. Pacher P, Liqudet L, Bai P, Mabley JG, Kaminski PM, Virag L, Deb A, Szabo E, Ungvari Z, Wolin MS, Groves JT, Szabo C (2003). Potent metalloporphyrin peroxynitrite decomposition catalyst protects against the development of doxorubicin induced cardiac dysfunction. Circ., 107: 896-904.
59. Palmer RM, Ashton DS, Moncada S (1988). Vascular endothelial cells synthesize nitric oxide from L. arginine. Nat., 333: 664-666.
60. 2+ increase and apoptosis in rat cardiomyocytes Biol. Pharma. Bull., 31(5): 809-815.
61. Pothitirat W, Gritsanapan W (2006). Variation of bioactive components in Curcuma longa in Thailand Current Sci., 91(10): 1397-1400.
62. Potluri S, Ventura HO, Mulumudi M, Mehra MR (2004). Cardiac troponin levels in heart failure. Cardiol. Rev., 12: 21-25.
63. Quiles JL, Huertas JR, Battino M, Mataix J, Ramirez MC (2002). Antioxidant nutrients and adriamycin toxicity. Toxicol., 180: 79-95.
64. Quiles JL, Huertas JR, Battino M, Mataix J, Ramirez-Tortosa C (2002). Antioxidant nutrients and adriamycin toxicity. Toxicology, 180: 79-95.
65. Radha KM, Anoop KS, Jaya G, Rikhab GS (2006). Multiple biological activities of curcumin: Ashort review. Life Sci., 78: 2081-2087.
66. Ramsewak RS, De Witt DL, Nair MG (2000). Cytotoxicity, antioxidant and anti-inflammatory activites of curcumins I-III from Curcuma longa. Phytomed., 7: 303-308.
67. Reif DW (1992). Ferritin as a source of iron for oxidative damage. Free Radical Biol. Med., 12(5): 417-427.
68. Reuge C (1968). Standardization method for hemoglobin determination. Rev. Fr. Transfus., 11: 45-50.
69. Ruiz-Larrea M B, Leal AM, Liza M, Lacort M, de Groot H (1994). Antioxidant effects of estradiol and 2-hydroxy estradiol on iron induced lipid per oxidation of rat liver microsome steroid, 59: 383-388.
70. Santos RV, Batista ML, Caperuto EC, Costa Rosa LF (2007). Chronic supplementation of creatine and vitamins C and E increases survival and improves biochemical parameters after doxorubicin treatment in rats. Clin. Exp. Pharmacol., 34(12): 1294-1299.
71. Schinell GR, Tournier HA, Prieto JM, Rios JL (2002). Antioxidant activity of anti-inflammatory plant extracts. Life Sci., 70: 1023-1033.
72. Simunek T, Strrba M, Popelova O, Adamcova M, Hardina R, Gersl V (2009). Anthracycline - induced cardiotoxicity: overview of studies examining the roles of oxidative stress and free cellular iron. Pharmacol. Rep., 61(1): 154-171.
73. Singal PK, Li T, Kumar D, Danelisen I, Iliskovic, N (2000).Adriamycininduced heart failure. mechanism and modulation. Mol. Cell. Biochem., 207: 77-85.
74. Sreejayan N, Rao MNA, Priyadarsini KI, Devasagayam TPA (1997). Inhibition of radiation - induced lipid peroxidation by curcumin. Int. J. Pharma., 151: 127-130.
75. Srivastava G, Mehta JL (2009). Currying the heart: Curcumin and Cardioprotection. J. Cardiovasc Pharmacol. Ther., 14(1): 22-27.
76. Szasz G, Waldenstrom J, Gruber W (1979). Creatine kinase in serum. Inhibition by endogenous polyvalent cations and the effect of chelators on the activity and stability of some assay components. Clin. Chem., 25: 446-452.
77. Vasquez - Vivar J, Martasek P, Hogg N, Masters BS, Pritchard KA, Kalyanaraman B (1997). Endothelial nitric oxide synthase dependent superoxide generation from adriamycin. Biochemistry., 36: 11293-11297.
78. Venkatesan N (1998). Curcumin attenuation of acute adriamycin myocardial toxicity in rats. Br. J. Pharm., 12: 425-427.
79. Wang GY, Wang YM, Zhang LN, Li Q, Yue H, Song CM, Feng JK (2007). Effect of resveratrol on heart function of rats with adriamycin failure Zhongyuo Zhong Yao Za Zhi, 32(15): 1563-1565.
80. Wattanapitayakul SK, Chularojmonri L, Herunsalee A, Charuchongkolwongse S, Niumsakwl S, Bauer JA (2005). Screening of antioxidants from medicinal plants cardioprotective effect against doxorubicin toxicity. Basic Clin. Pharmacol. Toxicol., 96: 80-87.
81. Wattanapitayakul SK, Chularojmontri L, Herunsalee A, Charuchongkolwongse S, Niumsakul S Bauer JA (2005). Screening of antioxidants from medicinal plants for cardioprotective effect against doxorubicin toxicity. Basic Clin. Pharmacol. Toxicol., 96: 80- 87.
82. 2+ in serum denatured with guanidine hydrochloride. Clin. Chem., pp. 232-237.
83. Wu Y, Chen Y, Xu J, Lu L (2002). Anticancer activities of curcumin on human Burkitt's lymphoma. Zhonghua Zhong Liu Zu Zhi, 24: 348-352.
84. Yee KC, Mukherjee D, Smith DE, Kline-Rogers EM, Fang J, Mehta RH, Almanaseer Y, Akhras E, Cooper JV and Eagle KA (2003). Prognostic significance of an elevated creatine kinase in the absence of an elevated troponin I during an acute coronary syndrome. Am. J. Cardiol., 92: 1442-1444.
85. Yilmaz S, Atessahin A, Sanna E, Karahan I, Songul D (2006). Protective effect of lycopene on adriamycin-induced cardiotoxicity and nephrotoxicity. Toxicol., 218: 164-171.
86. Yoshikawa T, Handa S, Suzuki M, Nagami K (1994). Abnormalities in sympathoneuronal regulation are localized to failing myocardium in rabbit heart. J. Am. Coll. Cardiol., 24: 210-215.
87. Young DS (1995). Effects of drugs on Clinical Laboratory tests, 4th ed. Acc press.
88. Zhou S, Starkov A, Froberg MK, Leino RL, Wallace KB (2001). Cumulative and irreversible cardiac mitochondrial dysfunction induced by doxorubicin. Cancer Res., 61: 771-777.